(Q40589732)

21 September 2017

1 reference

title

Muscle function and origin of pain in fibromyalgia (English)

1 reference

21 September 2017

0 references

Bennett RM

1

1 reference

21 September 2017

Jacobsen S

series ordinal

2

1 reference

21 September 2017

language of work or name

1 reference

1 November 1994

1 reference

Bailliere's clinical rheumatology

21 September 2017

1 reference

21 September 2017

8

1 reference

21 September 2017

721-746

1 reference

21 September 2017

4

1 reference

Psychological factors associated with primary fibromyalgia syndrome

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Psychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Mechanisms of exercise-induced delayed onset muscular soreness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Positive and negative muscular work

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Observations on experimental muscular soreness

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Skeletal muscle function in primary fibromyalgia. Effect of regional sympathetic blockade with guanethidine

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Histological abnormalities in muscle from patients with certain types of fibrositis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Donnan potentials from the A- and I-bands of glycerinated and chemically skinned muscles, relaxed and in rigor

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Regional sympathetic blockade in primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Primary fibromyalgia. A clinical and laboratory study of 55 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Muscle biopsy in primary fibromyalgia. Light-microscopical and histochemical findings

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Reduced high-energy phosphate levels in the painful muscles of patients with primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Diagnostic epidural opioid blockade in primary fibromyalgia at rest and during exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The Origin of Myopain:

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Aerobic fitness in patients with fibrositis. A controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Symptoms of Raynaud's syndrome in patients with fibromyalgia. A study utilizing the Nielsen test, digital photoplethysmography, and measurements of platelet α2-adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Low levels of somatomedin C in patients with the fibromyalgia syndrome. A possible link between sleep and muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Polymyositis and dermatomyositis (first of two parts)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Psychogenic Rheumatism: The Musculoskeletal Expression of Psychoneurosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical characteristics of fibrositis. I. A "blinded," controlled study of symptoms and tender points

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical characteristics of fibrositis. II. A "blinded," controlled study using standard psychological tests

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Skeletal muscle performance in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Growth hormone treatment in growth hormone-deficient adults. II. Effects on exercise performance

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Cardiovascular effects of growth hormone treatment in growth-hormone-deficient adults: stimulation of the renin-aldosterone system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The growth hormone deficiency syndrome in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A calcium(2+) ion-activated protease possibly involved in myofibrillar protein turnover. Partial characterization of the purified enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

In vivo 31P magnetic resonance spectroscopy (MRS) of tender points in patients with primary fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Evidence for impaired activation of the hypothalamic-pituitary-adrenal axis in patients with chronic fatigue syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Overuse syndrome: a muscle biopsy study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Mechanisms of skeletal muscle pain and fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Spectral analysis of EEG activity in different sleep stages in normal adults

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Simultaneous measurement of muscle conduction velocity and EMG power spectrum changes during fatigue

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical use of nuclear magnetic resonance in the investigation of myopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Increased EMG activity during short pauses in patients with primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Muscle performance, electromyography and fibre type composition in fibromyalgia and work-related myalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Delayed muscle soreness and cytoskeletal alterations: an immunocytological study in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A morphological study of delayed muscle soreness.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Sublethal muscle fibre injuries after high-tension anaerobic exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Transient decrease in number of motor units after immobilisation in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical and biochemical manifestations of depression. Relation to the neurobiology of stress (1)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Determination of dynamic muscle strength in man with acceleration controlled isokinetic movements

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

1 reference

7 January 2021

The early effects of ischemia upon skeletal muscle mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Muscle biopsy findings of possible diagnostic importance in primary fibromyalgia (fibrositis, myofascial syndrome)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Living with fibromyalgia. Consequences for everyday life

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Thirty-second sampling of plasma growth hormone in man: correlation with sleep stages

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Comorbidity of fibromyalgia with medical and psychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Experimental skeletal muscle damage: the nature of the calcium-activated degenerative processes

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Single cell morphology of muscle in patients with chronic muscle pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Oral S-adenosylmethionine in primary fibromyalgia. Double-blind clinical evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical features in patients with chronic muscle pain--with special reference to fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Somatization and depression in fibromyalgia syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Responses of group IV afferent units from skeletal muscle to stretch, contraction and chemical stimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Thin-fibre receptors responding to mechanical, chemical, and thermal stimulation in the skeletal muscle of the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Muscle changes in work-related chronic myalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Muscle tissue oxygen pressure in primary fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Growth hormone improves muscle protein metabolism and whole body nitrogen economy in man during a hyponitrogenous diet

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

In vivo muscle magnetic resonance spectroscopy in the clinical investigation of mitochondrial disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Investigative strategies for muscle pain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Induction of Neurasthenic Musculoskeletal Pain Syndrome by Selective Sleep Stage Deprivation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Plasma tryptophan and musculoskeletal pain in non-articular rheumatism (“fibrositis syndrome”)

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Musculosketal Symptoms and Non-REM Sleep Disturbance in Patients with “Fibrositis Syndrome” and Healthy Subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The consequences of eccentric contractions and their relationship to delayed onset muscle pain

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A Four-year Follow-up Study in fibromyalgia. Relationship to Chronic Fatigue Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Clinical aspects on 31P NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Illness worry and disability in fibromyalgia syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Is there a metabolic basis for the fibrositis syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Cerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Sleep and posttraumatic rheumatic pain modulation disorder (fibrositis syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The alpha-sleep pattern. Differentiation from other sleep patterns and effect of hypnotics.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Tenderness in 75 anatomic sites. distinguishing fibromyalgia patients from controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

A two year follow-up of somatic complaints among Israeli combat stress reaction casualties.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The contribution of reflex inhibition to arthrogenous muscle weakness.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Aircraft noise and mental health: I. Prevalence of individual symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Tender points in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Psychological symptoms in primary fibromyalgia syndrome: relationship to pain, life stress, and sleep disturbance.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Elevated CSF levels of substance P and high incidence of Raynaud phenomenon in patients with fibromyalgia: new features for diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Treatment of fibromyalgia (fibrositis syndrome): a parallel double blind trial with carisoprodol, paracetamol and caffeine (Somadril comp) versus placebo.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

No evidence for endorphin deficiency in fibromyalgia following investigation of cerebrospinal fluid (CSF) dynorphin A and Met-enkephalin-Arg6-Phe7

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Physiological effects of exhaustive physical exercise in primary fibromyalgia syndrome (PFS): is PFS a disorder of neuroendocrine reactivity?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Endurance training amplifies the pulsatile release of growth hormone: effects of training intensity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Evidence for a fatigue-induced reflex inhibition of motoneuron firing rates.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Juvenile primary fibromyalgia syndrome. A clinical study of thirty-three patients and matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Relationship of clinical features with psychological status in primary fibromyalgia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

Quantitative EMG and muscle tension in painful muscles in fibromyalgia

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3579%2805%2980045-7

7 January 2021

10.1016/S0950-3579(05)80045-7

Identifiers

DOI

1 reference

release_jzh53eygqzcgzji24ldxpsdhpm

21 September 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jzh53eygqzcgzji24ldxpsdhpm

24 November 2022

mapped directly with Wikidata item

1 reference